Guildford, UK and Cambridge, MA, September 24, 2009 – IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, today announced that IDBS customer Dr. Martin Vanderlaan, Director, Analytical Operations at Genentech, will present “Implementing an Electronic Lab Notebook for a Large Bioprocess Organisation,” at IQPC’s ELN and Advanced Lab Solutions Conference in Brussels, Belgium. Dr. Paul Denny-Gouldson, Product Manager at IDBS, will also present a session on “Data Management as the Foundation of ELNs as a Knowledge Base”.
Pharma IQ’s ELNs conference is Europe’s leading event for professionals working within laboratory data management in the Pharmaceutical and Biotech Industry. It consistently delivers a high volume of the most critical, time-specific practical case studies and strategic briefings.
Dr. Vanderlaan’s case study will highlight the pilot implementation of an ELN solution, covering the IT roadmap for a completely electronic records environment; organizational change management; the best strategy and planning for ELN selection and implementation; and key lessons learned.
Dr. Denny-Gouldson’s session will demonstrate how the right data management technology can support cross-study, cross-project, and cross-domain search and reporting. Examples of workflows gathered from across the industry will be presented including the “One Click IND” and “Automated Compound Progression” and how these require both data management and data federation to be successful.
Dr. Vanderlaan has been with Genentech for 14 years, most recently as the Director of Analytical Operations. Previously he was Director of Immunochemistry, PerseptiveBiosystemsHead, Hybidoma Group, Lawrence Livermore National Laboratory. He is a technical expert in Analysis of BioPharmaceuticals using chromatography, immunoassays, and potency assays and has authored more than 80 publications and patents. Dr Vanderlaan holds a PhD. From New York University Medical School and an MBA from the University of San Francisco.
Dr. Denny-Gouldsonhas almost 15 years’ experience in pharmacology, pharmaceutical drug development and ELN software development. He joined IDBS in 2005 when the company he founded, Deffinity Solutions was purchased by IDBS. Prior to this, he was Senior Scientist at Sanofi-Synthelabo (now Sanofi-Aventis). Dr. Denny-Gouldson obtained his PhD. in Computational Biology from Essex University in1996 and has authored over 20 scientific papers and book chapters.
The ELN and Lab Solutions conference will be held September 29-30, 2009, at The Renaissance Hotel, Brussels, Belgium. Dr. Denny-Gouldson will present on September 29 at 11:45 am and Dr. Vanderlaan will present on September 29 at 3:45 pm. For more information on the conference and these sessions visit www.elnforum.com.
IDBS is a trusted provider of integrated data management software and service solutions to both the life science and non-life science industries. The company’s ActivityBase and E-WorkBook Suites provide gold standard chemistry and biology data support from target validation to GxP validated phases of the R&D process. The company supports long term relationships with the leading research organizations, maximizing the value of research data by enabling the capture, storage, sharing and use of data, while protecting intellectual property across the spectrum of research activities. As part of its technology partner program, IDBS currently includes SAFE BioPharma Association, Microsoft, Oracle, Advanced Chemistry Development Inc, PerkinElmer and Titian. IDBS’ current commercial partners include SVS, a-tune, KooPrime and CTC-LS.
Headquartered in Guildford, UK, IDBS has worldwide coverage, with U.S. offices in California, New Jersey and Massachusetts, consultancy teams across Europe and a network which delivers IDBS products and advisory services across Asia. Founded in 1989, IDBS employs more than 170 people worldwide.